And today, it is much larger than it was way back when Buffett started buying it. So, could Coca-Cola be a millionaire maker today? The answer is most likely yes, but it is no longer a fast ...

After 78 regular-season games, one 60-minute contest between the Winnipeg Jets and the Dallas Stars could decide a divisional winner — and with it, the spoils that come along with the banner.

Democrats are continuing to sound the alarm about President Donald Trump’s retaliatory global tariffs, warning Trump administration officials that they will severely impact the medical supply ...

GOP candidate Curtis Sliwa boldly stated Tuesday there’s a “real probability” he could be New York City’s next mayor – insisting incumbent Eric Adams’ independent run and simmering ...

The trade policies may lead Coca-Cola to increase prices for U.S. buyers and could affect its progress on sustainability goals. But one expert says it’s not just tariffs that are a threat to the ...

What happens with the military could also be important, as that might be an attractive market, as well. But the really big event that might take place in 2025 isn't likely to happen domestically.

Apple is said to be working on adding an AI Doctor to its Health app on iPhones(Getty Images via AFP) Apple seems to betting big on the artificial intelligence once again with plans to completely ...

China has been urged to introduce a retiree visa for foreign nationals to boost its elderly care industry and improve the country’s international image. Jia Qingguo, a delegate to the Chinese ...

“What’s past is prologue,” Shakespeare wrote in The Tempest. This is good advice for stock market investors. A look back at recessions over the last 50 years shows that the market can reset ...

In a briefing released by the NWS Sunday afternoon, officials stated it was possible some scattered severe storms could develop in Kentucky and southern Indiana ahead of the main line of storms.

A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a therapy reserved for the ultra-rich. But Chinese biotech start-ups are aiming to ...